Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/25 18:48 | 8/12/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Smith Hunter C | MA | O | CFO | 3 | S.dm | -7,531 | 80.46 | 0 | -94 | 117 | D | |||||||||||||||
8/14/25 18:47 | 8/12/25 | RYTM | Health | Drug | Pharmaceutical Preparations | German Christopher Paul | MA | O | Corporat | 3 | S.d | -590 | 79.84 | 0 | -7 | 2 | D | |||||||||||||||
8/13/25 18:32 | 8/11/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Shulman Joseph | MA | O | Chief Te | 2 | S.d | -979 | 81.88 | 0 | -12 | 9 | D | |||||||||||||||
7/29/25 18:56 | 7/29/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Cramer Pamela J. | MA | O | CHRO | 3 | S.d | -1,810 | 75.04 | 0 | -24 | 21 | D | |||||||||||||||
7/3/25 17:12 | 7/2/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Garfield Alastair | MA | O | Chief Sc | 1 | S.d | -85 | 64.81 | 0 | -1 | 3 | D | |||||||||||||||
6/5/25 16:16 | 6/3/25 | RYTM | Health | Drug | Pharmaceutical Preparations | McGirr David W J | MA | D | 1 | S.d | -4,267 | 65.22 | 0 | -65 | 3 | D | ||||||||||||||||
6/5/25 16:16 | 6/3/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Meeker David P | MA | DO | P,CEO | 1 | S.d | -2,837 | 65.05 | 0 | -44 | 202 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |